We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns Indian Generics, API Manufacturer for Testing Issues
FDA Warns Indian Generics, API Manufacturer for Testing Issues
August 1, 2011
The FDA has warned Indian active pharmaceutical ingredient (API) and generics maker Zydus Group, a division of Cadila Healthcare, for a number of cGMP violations, including incomplete test data.